E2F6 and glioblastoma: Elsewhere, in genome-wide CRISPR KO screening studies with the GeckOv2 library, E2F6 was upregulated in epidermal growth factor receptor (EGFR)-mutant U87 GBM cells expressing mutant EGFRvIII upon TMZ treatment [74].